UK markets close in 5 hours 28 minutes

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
47.51-0.52 (-1.08%)
At close: 04:00PM EDT
49.30 +1.79 (+3.77%)
Pre-market: 04:23AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12131211
Avg. Estimate-0.55-0.37-1.231.2
Low estimate-0.83-0.6-2.180.13
High estimate-0.280.090.462.28
Year ago EPS-1.56-1.02-4.45-1.23
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14141413
Avg. Estimate161.78M187.99M795.83M1.18B
Low estimate137.45M162.63M719.23M936.9M
High estimate178.58M228.28M919.78M1.57B
Year ago sales44.85M70.25M396.59M795.83M
Sales growth (year/est)260.70%167.60%100.70%48.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.46-1.32-0.85-0.69
Actual EPS-1.56-1.02-1.17-0.73
Difference-0.10.3-0.32-0.04
Surprise %-6.80%22.70%-37.60%-5.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.55-0.37-1.231.2
7 days ago-0.55-0.37-1.231.2
30 days ago-0.54-0.37-1.181.2
60 days ago-0.52-0.35-1.011.56
90 days ago-0.57-0.42-1.441.11
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days111N/A
Up last 30 days112N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesAPLSIndustrySector(s)S&P 500
Current qtr.64.70%N/AN/AN/A
Next qtr.63.70%N/AN/AN/A
Current year72.40%N/AN/AN/A
Next year197.60%N/AN/AN/A
Next 5 years (per annum)33.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A